Source: ALL

Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.400 Biomarker BEFREE We have coupled two of these therapeutic approaches, gene therapy and antiangiogenic therapy and tested them in two murine prostate cancer models Recombinant adenovirus encoding the ligand-binding ectodomain of the VEGF receptor 2 (Flk1) fused to an Fc domain was administered to SCID mice carrying orthotopic human LNCaP tumors as well as to transgenic (TRAMP) mice with spontaneous prostate tumors. 12496487

2003
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.400 AlteredExpression LHGDN Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells. 12839933

2003
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.400 Biomarker CTD_human Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for prostate cancer. 12893367

2003
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.400 GeneticVariation LHGDN Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for prostate cancer. 12893367

2003
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.400 AlteredExpression LHGDN MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer. 12168088

2002
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.400 Biomarker LHGDN Vascular endothelial growth factor and signaling in the prostate: more than angiogenesis. 12039075

2002
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.400 AlteredExpression BEFREE Our observations suggest that VEGF expression could be used as a prognostic marker in early-stage prostate tumors, whereas neuropilin-1 overexpression might be a marker of aggressiveness. 10754495

2000